Enerpac Tool Group Corp. (EPAC)
NYSE: EPAC · Real-Time Price · USD
37.51
-1.00 (-2.60%)
Aug 1, 2025, 4:00 PM - Market closed
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$53.00
Upside
+41.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| CJS Securities | CJS Securities | Buy Initiates $53 | Buy | Initiates | $53 | +41.30% | Mar 14, 2025 |
| CL King | CL King | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | -6.69% | Oct 25, 2023 |
| RBC Capital | RBC Capital | Sell Maintains $19 → $18 | Sell | Maintains | $19 → $18 | -52.01% | Jun 29, 2022 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $23 | Hold → Buy | Upgrades | $23 | -38.68% | Jun 22, 2022 |
| RBC Capital | RBC Capital | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Jan 5, 2022 |
| RBC Capital | RBC Capital | Hold Maintains $21 → $20 | Hold | Maintains | $21 → $20 | -46.68% | Dec 22, 2021 |
| Wells Fargo | Wells Fargo | Sell → Hold Upgrades $22 | Sell → Hold | Upgrades | $22 | -41.35% | Nov 2, 2021 |
| Wells Fargo | Wells Fargo | Sell Maintains $22 → $20 | Sell | Maintains | $22 → $20 | -46.68% | Sep 30, 2021 |
| RBC Capital | RBC Capital | Hold Maintains $26 → $22 | Hold | Maintains | $26 → $22 | -41.35% | Sep 30, 2021 |
| RBC Capital | RBC Capital | Hold Maintains $26 → $28 | Hold | Maintains | $26 → $28 | -25.35% | Jun 30, 2021 |
| RBC Capital | RBC Capital | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | -30.69% | Jun 24, 2021 |
| Wells Fargo | Wells Fargo | Hold → Sell Downgrades $22 | Hold → Sell | Downgrades | $22 | -41.35% | Jun 8, 2021 |
| CJS Securities | CJS Securities | Buy Initiates $32 | Buy | Initiates | $32 | -14.69% | Mar 19, 2021 |
| Wells Fargo | Wells Fargo | Hold Maintains $25 → $20 | Hold | Maintains | $25 → $20 | -48.01% | Mar 16, 2020 |